Advertisement
The Leading Source for Pharmaceutical & Biopharmaceutical Manufacturing News
Subscribe to Pharmaceutical Processing

The Lead

HHS Contracts with Mapp Biopharmaceutical to Develop Ebola Drug

September 2, 2014 | News | Comments

The development of a medication to treat illness from Ebola will be accelerated under a contract with the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR). This contract supports the government-wide response to the Ebola outbreak in West Africa.

TOPICS:
View Sample

FREE Daily Email Newsletter

Tablet Hardness Tester

September 2, 2014 3:44 pm | by Nikita Ernst, Associate Editor | Natoli Engineering Co., Inc. | Product Releases | Comments

Introducing an economical and simple-to-use stainless steel tablet hardness tester that accurately calculates the hardness and thickness of solid dosage forms.

Gas Detector Tube System

September 2, 2014 3:37 pm | by Nikita Ernst, Associate Editor | Nextteq, LLC | Product Releases | Comments

The line of Gastec pumps and detector tubes precisely measure gases and vapors in over 600 applications, making it a suitable tool for gas detection and measurement as well as detecting leaks and fugitive emissions.

Semi-Automatic Case Packer

September 2, 2014 3:28 pm | by Nikita Ernst, Associate Editor | Omega Design Corp. | Product Releases | Comments

Introducing the ECX-001 Case Packer, a jointly-developed semi-automatic case packer with unit-level serialization capabilities that has been outfitted with best in class software, cameras, and printers to meet the more stringent track & trace requirements mandated by the Drug Quality and Security Act. 

TOPICS:
Advertisement

Particle Sciences Expands Drug Eluting Device Capabilities and Overall Clinical Trial Manufacturing Resources

September 2, 2014 2:39 pm | News | Comments

Particle Sciences, a CDMO for drug eluting devices, has added to its investment in development and manufacturing capabilities with the addition of a new 18mm extruder. The company now has over 6000ft2 of operating cleanroom and cGMP warehouse space including ISO5 (sterile) and two dedicated highly potent suites.

TOPICS:

Actavis Announces FDA Acceptance for Filing of NDA for Eluxadoline

September 2, 2014 9:34 am | News | Comments

Actavis plc today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing Actavis' New Drug Application (NDA) for eluxadoline, an investigational drug for the treatment of diarrhea and abdominal pain in men and women with diarrhea predominant Irritable Bowel Syndrome (IBS-D).

TOPICS:

New Drug to Treat Congestive Heart Failure Shows Promise

September 2, 2014 9:26 am | Videos | Comments

Doctors say that new treatment could be a big breakthrough to help those affected by the condition.                          

TOPICS:

EMD Serono Appoints New Senior Vice President, Neurology and Immunology

September 2, 2014 9:09 am | News | Comments

EMD Serono announced today that Drew Young has joined the company as Senior Vice President, Neurology and Immunology. In this capacity, he will be responsible for leading the strategic direction of the U.S. Neurology and Immunology franchise, including future products.

TOPICS:

Regeneca Worldwide Expands Voluntarily Recall of Regeneslim Appetite Control Capsules

September 2, 2014 9:04 am | News | Comments

Regeneca Worldwide a division of VivaCeuticals, Inc. Las Vegas, NV is expanding the voluntary nationwide recall of its RegeneSlim appetite control dietary supplement to include lot #823230415, lot #EX0616r 15813, Lot # EX0616R15814 and Lot #11414re5516 because FDA analysis confirmed the presence of DMAA.

TOPICS:
Advertisement

Zohydro ER Demonstrates Sustained 12-Hour Pain Relief

September 2, 2014 8:57 am | News | Comments

Zogenix today announced new post-hoc analysis data showing that the indicated 12-hour dose of Zohydro(R) ER,(hydrocodone bitartrate) Extended-Release Capsules, CII, provided durable pain relief over the entire dosing interval.     

TOPICS:

Experimental Ebola Drug Heals All Monkeys in Study

September 2, 2014 8:43 am | by MARILYNN MARCHIONE, AP Chief Medical Writer | News | Comments

The monkeys were given the drug, ZMapp, three to five days after they were infected with the virus and when most were showing symptoms. That is several days later than any other experimental Ebola treatment tested so far.     

TOPICS:

Survey: Pharmaceutical and Other Foreign Companies in China Feel 'Targeted'

September 2, 2014 8:14 am | by JOE McDONALD, AP Business Writer | News | Comments

Foreign companies in China feel increasingly targeted for unfair enforcement of anti-monopoly and other laws and might cut investment if conditions fail to improve, a U.S. business group said Tuesday.         

TOPICS:

Pfizer and Protalix BioTherapeutics Announce FDA Approval of Pediatric Indication for ELELYSO™

August 28, 2014 1:41 pm | News | Comments

Pfizer and Protalix BioTherapeutics announced that the FDA approved ELELYSO™ for injection for pediatric patients. ELELYSO is therefore now indicated for long-term enzyme replacement therapy (ERT) for adult and pediatric patients with a confirmed diagnosis of Type 1 Gaucher disease.

TOPICS:

DPx Holdings B.V. Reaches Definitive Agreement to Acquire Gallus BioPharmaceuticals

August 28, 2014 11:55 am | News | Comments

DPx Holdings B.V., privately owned by JLL Partners and Royal DSM, has reached a definitive agreement to acquire all shares of Gallus BioPharmaceuticals, LLC, a contract manufacturing company specializing in biologics and current portfolio company of Ridgemont Equity Partners.

TOPICS:

Sterility Testing Pumps

August 28, 2014 11:52 am | by Nikita Ernst, Associate Editor | EMD Millipore Corporation | Product Releases | Comments

Introducing Steritest™ Symbio Pumps for easier, safer and more reliable sterility testing of pharmaceutical products in laminar flow hoods, isolators and clean rooms.

Novo Nordisk Buys Production Plant in New Hampshire

August 28, 2014 11:47 am | News | Comments

The facility was established in 1989, expanded in 2003-2006 and acquired by Olympus Biotech in 2011. It has been used primarily for mammalian cell manufacturing until production was phased out earlier this year.       

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading